Blood Transfusion Diagnostics Market is predicted to touch USD 2.45 billion at an 8.2% CAGR between 2017-2023, reveals the latest Market Research Future (MRFR) report. Blood transfusion, simply put, is a life-saving procedure that replaces blood cells that are lost through severe bleeding during surgical procedures or in the case of patients suffering from anemia who require blood for increasing blood count. There are several medical problems or conditions which may need various forms of transfusion, including plasma, platelets, and red cells, such as during childbirth, pregnancy, blood problems, operations, or cancer. Blood transfusion diagnostics comprise of instruments such as kits and reagents, centrifuges, and analyzers that are used for different tests such as disease screening or blood grouping for patients and donors alike.
Various factors are propelling the blood transfusion diagnostics market growth. These factors, as per the new Market Research Future (MRFR) report, include government schemes for paid and voluntary blood donation, huge patient population suffering from chronic diseases especially leukemia, sickle cell anemia, and aplastic anemia, increasing awareness about automation of blood banks and blood transfusions, and strict regulations pertaining to the use as well as transfer of blood. Additional factors pushing market growth include demand for screened blood products, availability of different blood transfusion procedures, and increasing incidence of infectious diseases.
Get Exclusive Sample Copy of “Blood Transfusion Diagnostics Market” Report @ https://www.marketresearchfuture.com/sample_request/1126
On the flip side, lack of skilled experts for blood transfusion diagnostics, high operating price of testing, stringent regulatory policies for approvals, availability of alternative treatments, and increasing incidence of complications during the transfusion procedure are factors that may restrict the blood transfusion diagnostics market growth over the forecast period.
Key Players – Blood Transfusion Diagnostics Market
Major players profiled in the blood transfusion diagnostics market report include Biokit (Spain), Hologic/Gen-Probe (US), Quidel (US), Grifols (Spain), Fujirebio (Belgium), DiaSorin (Italy), BAG Healthcare (Germany), Abbott Diagnostics (US), Diagast (France), Beckman Coulter, Inc. (US), Novartis AG (Switzerland), Dickinson and Company (US), Becton, Ortho Clinical Diagnostics, Inc. (US), Siemens Healthineers (Germany), Bio-Rad Laboratories, Inc. (US), BioMérieux (France), Roche Diagnostics (Switzerland), Thermo Fisher Scientific, Inc. (US), Grifols (Spain), Beckman Coulter (US), Immucor (US), and Ortho Clinical Diagnostics (US).
Blood Transfusion Diagnostics Industry News
October 2019: Japanese scientists have created artificial blood in the laboratory, which can be transfused in patients irrespective of the blood type. It will help those who fail in getting immediate treatment during emergencies or times of need.
In June 2019, Dubai Health Authority (DHA) announced the launch of its blood donation campaign, ‘Be the Hero … Save Lives’ for encouraging donators and creating awareness.
In June 2019, The American Chamber of Commerce in Việt Nam (AmCham Vietnam) collaborated with HCM City Institute of Hematology, and Blood Transfusion organized a blood donation campaign to celebrate the World’s Blood Donor Day on 14th of the month.
Segments – Blood Transfusion Diagnostics Market
The MRFR report provides an all-inclusive segmental analysis of the blood transfusion diagnostics market on the basis of blood product, technology, and end users.
Based on the blood product, the blood transfusion diagnostics market is segmented into immunoglobulin preparations, albumin, plasma, platelets, red blood cells, and other products.
By technology, the global blood transfusion diagnostics market is segmented into rapid test, fluorescence assay, nucleic acid amplification, ELISA, western blot, and other technologies. The ELISA segment is again segmented into colorimetric immunoassay (CI), fluorescence immunoassays (FIA), and chemiluminescence immunoassay. The nucleic acid amplification segment i again segmented into real-time PCR and thermomechanical analysis (TMA).
Based on end users, the blood transfusion diagnostics market is segmented into laboratories, blood banks, clinics, and hospitals. Of these, the blood banks segment will dominate the market over the forecast period chiefly due to the increase in the number of blood centers and blood banks worldwide.
Regional Analysis – Blood Transfusion Diagnostics Market
By region, the blood transfusion diagnostics market report covers the latest trends and growth opportunities across the Asia Pacific (APAC), the Americas, Europe, and the Middle East and Africa (MEA). Of these, the Americas will have the lion’s share in the market over the forecast period. Factors aiding growth in the region include strict rules related to transfusion and storage of blood, automation of blood banks, and growing adoption of nucleic acid implication test of diagnosis. Moreover, various awareness programs and camps conducted by the non-government organization for safe handling of blood is also boosting the market growth.
The blood transfusion diagnostics market in Europe is predicted to have the second-largest share in the market over the forecast period. Factors aiding growth in the region include the collaboration of government bodies with NGO’s, availability of skilled healthcare professionals in the region, and burgeoning demand for improved diagnostics tests.
The blood transfusion diagnostics market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in the region include the adoption of new technology, the growing number of donors in the region, and the presence of several key players. Japan is the chief contributor in the region.
The blood transfusion diagnostics market in the MEA is predicted to have steady growth over the forecast period.
Browse Complete “Blood Transfusion Diagnostics Market” Report @ https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar